ROSUMEGA Trademark

Trademark Overview


On Tuesday, October 24, 2017, a trademark application was filed for ROSUMEGA with the United States Patent and Trademark Office. The USPTO has given the ROSUMEGA trademark a serial number of 79222738. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, February 14, 2025. This trademark is owned by Kuhnil Pharm. Co., Ltd.. The ROSUMEGA trademark is filed in the Pharmaceutical Products category with the following description:

Chemico-pharmaceutical preparations for the treatment of dyslipidemia; preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of cardiovascular disease; drugs for medical purposes, namely, for the treatment of dyslipidemia; cardiovascular pharmaceutical preparations; chemotherapeutics; hypoglycemic agents; anticoagulants; antibiotic preparations; antihypertensives; dermatological pharmaceutical products; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for tumor treatment; pharmaceutical agents affecting digestive organs; pharmaceutical preparations for activating cellular function; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; anti-inflammatory preparations; pharmaceutical preparations for urogenital organs; pharmaceutical preparations for immunity adjustment
rosumega

General Information


Serial Number79222738
Word MarkROSUMEGA
Filing DateTuesday, October 24, 2017
Status709 - CANCELLED - SECTION 71
Status DateFriday, February 14, 2025
Registration Number5527049
Registration DateTuesday, July 31, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 15, 2018

Trademark Statements


Goods and ServicesChemico-pharmaceutical preparations for the treatment of dyslipidemia; preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of cardiovascular disease; drugs for medical purposes, namely, for the treatment of dyslipidemia; cardiovascular pharmaceutical preparations; chemotherapeutics; hypoglycemic agents; anticoagulants; antibiotic preparations; antihypertensives; dermatological pharmaceutical products; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for tumor treatment; pharmaceutical agents affecting digestive organs; pharmaceutical preparations for activating cellular function; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; anti-inflammatory preparations; pharmaceutical preparations for urogenital organs; pharmaceutical preparations for immunity adjustment

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 14, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKuhnil Pharm. Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameKuhnil Pharm. Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameKuhnil Pharm. Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Tuesday, December 19, 2017APPLICATION FILING RECEIPT MAILED
Monday, February 5, 2018NON-FINAL ACTION WRITTEN
Thursday, December 14, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, December 15, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 1, 2018ASSIGNED TO EXAMINER
Friday, March 2, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 14, 2018ASSIGNED TO LIE
Friday, March 16, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 16, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 6, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 25, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 15, 2018PUBLISHED FOR OPPOSITION
Tuesday, May 15, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 31, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, October 31, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, November 17, 2018FINAL DISPOSITION NOTICE SENT TO IB
Monday, July 31, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, February 14, 2025CANCELLED SECTION 71
Friday, December 7, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, February 6, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, February 8, 2018REFUSAL PROCESSED BY MPU
Thursday, February 8, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, February 24, 2018REFUSAL PROCESSED BY IB
Friday, November 16, 2018FINAL DISPOSITION PROCESSED